Inactive Instrument

Golden Meditech Holdings Limited

Equities

801 KYG395801247

Medical Equipment, Supplies & Distribution

Golden Meditech Announces Resignation of Gao Zong Ze, Non-Executive Director

September 22, 2014 at 09:06 am EDT

The board of directors of Golden Meditech announced that Mr. Gao Zong Ze resigned as an independent non-executive Director with effect from 19 September 2014 due to Mr. Gao's desire to devote more time to his personal endeavours.

Latest news about Golden Meditech Holdings Limited

Golden Meditech Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-30	CI
Golden Meditech Holdings Limited Reports Earnings Results for the Six Months Ended September 30, 2019	19-11-27	CI
Golden Meditech Holdings Limited(SEHK:801) dropped from S&P Global BMI Index	19-09-23	CI
Golden Meditech Holdings Limited Reports Earnings Result for the Year Ended March 31, 2019	19-06-28	CI
Golden Meditech Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended March 31, 2019	19-06-03	CI
Golden Meditech Holdings Limited Announces Management Changes	19-05-24	CI
Golden Meditech Holdings Limited and Hong Kong Baptist University Team Up to Conduct Cell Therapy Research	19-04-17	CI
Golden Meditech Holdings Limited Announces Earnings Results for the Six Months Ended September 30, 2018	18-11-26	CI
Golden Meditech Holdings Limited Announces Group Earnings Results for the Year Ended March 31, 2018	18-06-27	CI
Golden Meditech Holdings Limited Provides Earnings Guidance for the Year Ended 31 March 2018	18-06-25	CI
Golden Meditech Holdings Limited Announces Board Changes	18-04-26	CI
Golden Meditech Holdings Limited Declares Special Dividend, Payable on or around 26 March 2018	18-02-13	CI
Tranche Update on Golden Meditech Holdings Limited's Equity Buyback Plan announced on October 30, 2017.	18-02-01	CI
Golden Meditech Holdings Limited‘s Equity Buyback announced on October 30, 2017, has expired with 49,207,566 shares, representing 1.66% for TWD 218.97 million	18-01-30	CI
Golden Meditech And Permira Leave Race For I-MED	17-12-04	CI
Golden Meditech Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2017	17-11-30	CI
Golden Meditech Holdings Limited's Board intends to launch an Equity Buyback.	17-10-30	CI
Golden Meditech Holdings Limited announces an Equity Buyback for 65,638,518 shares, representing 2.21% for TWD 292.09 million.	17-10-29	CI
Golden Meditech Holdings Limited authorizes a Buyback Plan.	17-10-29	CI
Asians Bow Out Of I-Med Sale	17-10-20	CI
Golden Meditech Holdings Limited Reports Earnings Results for the Year Ended March 31, 2017	17-06-28	CI
Golden Meditech Holdings Limited cancelled the acquisition of the remaining 57.97% stake in China Cord Blood Corporation (NYSE:CO).	17-04-12	CI
Kam Yuen completed the acquisition of an additional 32.66% stake in Golden Meditech Holdings Limited from Atlantis Investment Management (Hong Kong) Ltd., Kong Kam Yu and other shareholders for HKD 1.2 billion.	17-04-09	CI
Kam Yuen made an offer to acquire an additional 62.3% stake in Golden Meditech Holdings Limited from Atlantis Investment Management (Hong Kong) Ltd., Kong Kam Yu and other shareholders for HKD 2.3 billion.	17-01-12	CI
Golden Meditech Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2016	16-11-23	CI

Chart Golden Meditech Holdings Limited

Duration

Period

More charts

Company Profile

Golden Meditech Holdings Limited is a Hong Kong-based investment holding company principally engaged in medical businesses. The Company operates through four segments. Medical Devices segment is engaged in the development, manufacture and sales of medical devices and medical accessories. Hospital Management segment is engaged in the provision of hospital management services and hospital operation in China. Its hospitals include Beijing Qinghe Hospital and Shanghai East International Medical Center. Medical Insurance Administration segment is engaged in the provision of medical insurance administration services in China. Chinese Herbal Medicines segment is engaged in the research and development, manufacture and sales of Chinese herbal medicines.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-7.22%	178B
MEDTRONIC PLC	-6.72%	98.53B
BECTON, DICKINSON AND COMPANY	-7.50%	65.18B
DEXCOM, INC.	-10.57%	44.13B
CENCORA, INC.	+8.92%	44.05B
HOYA CORPORATION	+13.76%	42.51B
METTLER-TOLEDO INTERNATIONAL, INC.	+9.65%	28.41B
TERUMO CORPORATION	+21.35%	25.31B
WEST PHARMACEUTICAL SERVICES, INC.	-9.13%	23.31B

Other Medical Equipment, Supplies & Distribution